Last Updated: September 24, 2026

ALSUMA Drug Patent Profile

Name: ALSUMA Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Alsuma, and when can generic versions of Alsuma launch?

Alsuma is a drug marketed by Meridian Medcl and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in ALSUMA is sumatriptan succinate. There is one drug master file entry for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Alsuma

A generic version of ALSUMA was approved as sumatriptan succinate by HIKMA on February 6^th, 2009.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for ALSUMA?
What are the global sales for ALSUMA?
What is Average Wholesale Price for ALSUMA?

Summary for ALSUMA

US Patents:	1
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	93
Patent Applications:	1,992
DailyMed Link:	ALSUMA at DailyMed

Drug patent expirations by year for ALSUMA

US Patents and Regulatory Information for ALSUMA

ALSUMA is protected by one US patents.

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Meridian Medcl	ALSUMA	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	022377-001	Jun 29, 2010		DISCN	No	No	7,811,254	⤷ Start Trial	Y			⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for ALSUMA

See the table below for patents covering ALSUMA around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Canada	2666860		⤷ Start Trial
European Patent Office	2073866		⤷ Start Trial
Taiwan	200838574		⤷ Start Trial
World Intellectual Property Organization (WIPO)	2008048750		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.